We are live on ! Find out more
CMLFU

CM Life Sciences, Inc. Unit
CMLFU

Delisted

CMLFU was delisted on the 22nd of July, 2021.

Back to rankings

42 hedge funds and large institutions have $233M invested in CM Life Sciences, Inc. Unit in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less funds holding

Funds holding: 58 → 42 (-16)

41% less capital invested

Capital invested by funds: $393M → $233M (-$160M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

60% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 25

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

Holders
42
Holders Change
-16
Holders Change %
-27.59%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
6
Reduced
15
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$2.48M
2
GS
Gagnon Securities
New York
+$1.84M
3
GA
Gagnon Advisors
New York
+$1.43M
4
JG
Jefferies Group
New York
+$674K
5
BCM
Bluefin Capital Management
New York
+$500K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$22M
2
WMSA
Weiss Multi-Strategy Advisers
New York
-$21.9M
3
Millennium Management
Millennium Management
New York
-$21.4M
4
Blackstone Inc
Blackstone Inc
New York
-$16.5M
5
TCIM
TOMS Capital Investment Management
New York
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SHCM
1
Sachem Head Capital Management
New York
$40.2M – – –
MF
2
Magnetar Financial
Illinois
$33.6M -$3.25M -301,769 -9%
BCM
3
BlueCrest Capital Management
Jersey
$29M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$24.9M – – –
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$17.3M – – –
BCP
6
Berylson Capital Partners
Massachusetts
$11.6M – – –
DKCM
7
Davidson Kempner Capital Management
New York
$11M -$5.98M -554,570 -37%
YCMGA
8
York Capital Management Global Advisors
New York
$8.7M -$8.08M -750,000 -50%
IM
9
Islet Management
New York
$8.7M – – –
Millennium Management
10
Millennium Management
New York
$7.45M -$21.4M -1,989,997 -76%
GS
11
Gagnon Securities
New York
$7.25M +$1.84M +170,378 +38%
KC
12
Kepos Capital
New York
$6.38M -$5.57M -516,858 -48%
ACM
13
Arrow Capital Management
New York
$5.8M +$5.39M +500,000 New
GA
14
Gagnon Advisors
New York
$4.3M +$1.43M +132,776 +56%
Goldman Sachs
15
Goldman Sachs
New York
$2.67M +$2.48M +230,000 New
PC
16
Periscope Capital
Ontario, Canada
$2.32M – – –
ACM
17
Altium Capital Management
New York
$2.32M +$2.15M +200,000 New
SCM
18
Shaolin Capital Management
Florida
$1.74M -$2.15M -200,000 -57%
HF
19
HRT Financial
New York
$1.16M +$19.7K +1,830 +2%
JG
20
Jefferies Group
New York
$726K +$674K +62,556 New
FBCM
21
Fort Baker Capital Management
California
$683K -$2.6M -241,100 -80%
FTCM
22
First Trust Capital Management
Illinois
$651K -$609K -56,506 -50%
TD Asset Management
23
TD Asset Management
Ontario, Canada
$607K – – –
BCM
24
Bluefin Capital Management
New York
$538K +$500K +46,392 New
Wolverine Trading
25
Wolverine Trading
Illinois
$499K +$453K +42,000 New
1
2 3

CMLFU Hedge Fund Activity: Q4 2020 in Review

42 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q4 2020, worth a combined $233M — down 41% from $393M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CMLFU and 10 opened new positions — a net loss of 15 holders — while 15 trimmed existing stakes and 6 added.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.48M. The largest seller was Linden Advisors, exiting entirely with an estimated $22M sold.

  • 42 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q4 2020, down from 58 in Q3 2020.
  • Funds reported $233M of CM Life Sciences, Inc. Unit stock for Q4 2020, down 41% quarter-over-quarter.
  • 10 funds opened new CM Life Sciences, Inc. Unit positions in Q4 2020 and 25 closed out, a net change of -15 holders.
  • The largest CM Life Sciences, Inc. Unit buyer in Q4 2020 was Goldman Sachs, an estimated $2.48M added.
  • The largest CM Life Sciences, Inc. Unit seller in Q4 2020 was Linden Advisors, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2020.